A research team at the University of Osaka has unveiled the molecular mechanism behind genome ejection from adeno-associated virus (AAV) vectors, a crucial delivery vehicle in gene therapy. Subscribe ...

Accelerating and de-risking late pre-clinical drug development with the zebrafish tumor xenograft (ZTX) platform. Efficacy and safety data from Ph1b, dose optimization trial of two doses of TH1902 ...

A novel bioengineering strategy utilizing peptide display technology on the AAV1 capsid has successfully generated ...

Researchers develop a nanosensing platform that can assess the quality of individual viral vector particles Viral vectors hold much potential for gene editing and gene therapy, but there is a pressing ...